Cerity Partners
GMED icon

Cerity Partners’s Globus Medical GMED Stock Holding History

Cerity Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
22,021
-38,549
-64% -$3.28M ﹤0.01% 1668
2026
Q1 		$5.22M Buy
60,570
+24,938
+70% +$2.24M 0.01% 989
2025
Q4 		$3.11M Sell
35,632
-7,188
-17% -$546K ﹤0.01% 1157
2025
Q3 		$2.45M Sell
42,820
-5,686
-12% -$327K ﹤0.01% 1197
2025
Q2 		$2.86M Buy
48,506
+5,803
+14% +$375K 0.01% 1055
2025
Q1 		$3.13M Sell
42,703
-769
-2% -$63.5K 0.01% 928
2024
Q4 		$3.15M Sell
43,472
-2,278
-5% -$180K 0.01% 910
2024
Q3 		$3.27M Buy
45,750
+9,404
+26% +$664K 0.01% 876
2024
Q2 		$2.49M Sell
36,346
-6,221
-15% -$372K 0.01% 826
2024
Q1 		$2.28M Buy
42,567
+36,557
+608% +$1.97M 0.01% 914
2023
Q4 		$320K Buy
+6,010
New +$293K ﹤0.01% 1479
2023
Q2 		– Sell
-4,576
Closed -$259K – 1771
2023
Q1 		$259K Sell
4,576
-2,772
-38% -$178K ﹤0.01% 1597
2022
Q4 		$546K Buy
+7,348
New +$500K ﹤0.01% 902
2018
Q1 		– Sell
-5,137
Closed -$211K – 551
2017
Q4 		$211K Buy
+5,137
New +$180K 0.01% 523

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cerity Partners's GMED Position: Q2 2026 in Review

Cerity Partners reduced its Globus Medical (GMED) stake by 64% in Q2 2026, selling an estimated $3.28M and leaving 22,021 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Cerity Partners first reported a position in GMED in Q4 2017 and has held it in 14 quarters since. The position peaked at $5.22M in Q1 2026. 566 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cerity Partners held 22,021 shares of Globus Medical worth $1.74M as of Q2 2026.
  • Cerity Partners sold 38,549 Globus Medical shares in Q2 2026, an estimated $3.28M.
  • Globus Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1668 holding.
  • Cerity Partners first reported a position in Globus Medical in Q4 2017 and has held it in 14 quarters since.
  • Cerity Partners's Globus Medical position peaked at $5.22M in Q1 2026.
  • 566 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.